Diseases, Conditions, Syndromes

Investigational drug can reduce asthma flareups

An investigational drug appears to cut the risk of severe asthma attacks in half for patients who have difficulty controlling the disorder with standard medications, according to results from two multicenter clinical trials.

Diseases, Conditions, Syndromes

Recommending oral probiotics doesn't cut antibiotic use

(HealthDay)—Advising patients with asthma to take probiotics does not reduce antibiotic use, according to a study published in the September/October issue of the Annals of Family Medicine.

Inflammatory disorders

ERS: Mepolizumab is glucocorticoid-sparing in asthma

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published online Sept. ...

page 5 from 7